慢性肾脏病3期患者血尿酸及同型半胱氨酸水平与动脉硬化的相关性

梁艳; 戴晖; 漆荣堂; 杨春亮; 刘培明; 柴荣

doi:10.13201/j.issn.1001-1439.2020.11.008

慢性肾脏病3期患者血尿酸及同型半胱氨酸水平与动脉硬化的相关性

- 1 河南省人民医院河南省肾病重点实验室郑州大学人民医院肾内科(郑州, 450000);
- 2 新疆哈密十三师红星医院肾内科

详细信息

通讯作者: 戴晖,E-mail:liangyan_sy@163.com

中图分类号: R543

收稿日期: 2020-05-26

Correlations between serum uric acid and homocysteine levels and arteriosclerosis in patients with chronic kidney disease stage 3

- 1 Department of Nephrology, Henan Provincial People's Hospital, Key Laboratory of Nephropathy of Henan Province, People's Hospital of Zhengzhou University, Zhengzhou, 450000, China;
- 2 Department of Nephrology, Xinjiang Production and Construction Corps 13 Division Red Star Hospital

More Information

Corresponding author: DAI Hui, E-mail: liangyan_sy@163.com

Received Date: 26 May 2020

摘要

摘要: 目的:探讨慢性肾脏病(CKD)3期患者血尿酸(SUA)及同型半胱氨酸(Hcy)水平与动脉硬化(AS)的相关性。方法:检测140例CKD 3期患者的血浆SUA及Hcy水平,测量患者的颈动脉内膜中层厚度(IMT)、颈动脉斑块、肱踝脉搏波传导速度(ba-PWV),并根据IMT和颈动脉斑块将患者分为AS组和对照组。分析SUA、Hcy与AS指标的相关性,并采用Logistic回归分析SUA、Hcy是否是CKD 3期患者合并AS的影响因素;采用ROC曲线分析SUA、Hcy单独及联合诊断CKD 3期患者合并AS的性能。结果:AS组SUA、Hcy水平均显著高于对照组(P＜0.05);SUA及Hcy与IMT、ba-PWV均呈显著正相关性;高SUA、Hcy是CKD 3期患者合并AS的独立危险因素;SUA联合Hcy诊断CKD 3期合并AS的性能优于单一指标。结论:CKD 3期患者的SUA、Hcy水平与AS指标密切相关,二者联合可用于CKD 3期患者出现血管硬化的预测诊断。
- 慢性肾脏病 /
- 血尿酸 /
- 同型半胱氨酸 /
- 动脉硬化
Abstract: Objective: To investigate the correlations between the levels of serum uric acid(SUA) and homocysteine(Hcy) and arteriosclerosis(AS) in patients with chronic kidney disease stage 3(CKD3). Method: The plasma SUA and Hcy levels of 140 CKD 3 patients were test. The carotid intima-media thickness(IMT), carotid plaque and brachio ankle pulse wave velocity(ba-PWV) were measured and the patients were divided into the AS group(n=78) and control group(n=62) according to the IMT and carotid plaque. The correlations between SUA, Hcy and AS indexes were analyzed and Logistic regression was used to analyze whether they were the influencing factors of CKD3 patients complicated with AS. The performance of SUA and Hcy in the diagnosis of AS alone and in combination were analyzed by ROC curve. Result: The levels of SUA and Hcy in AS group were significantly higher than those in control group(P＜0.05). The level of SUA and Hcy were significantly positively correlated to IMT and ba-PWV. High SUA and Hcy were independent risk factors of AS. SUA combined with Hcy was superior to single index in the diagnosis of AS of CKD3 patients.Conclusion: SUA and Hcy in CKD 3 patients were closely related to AS indexes and the combination of the two could be used for diagnosis of AS in CKD 3 patients.
- chronic kidney disease /
- serum uric acid /
- homocysteine /
- atherosclerosis

HTML全文

参考文献(22)

[1]	Lv JC,Zhang LX.Prevalence and disease burden of chronic kidney disease[J].Adv Exp Med Biol,2019,1165:3-15.
[2]	Zhang L,Long J,Jiang W,et al.Trends in chronic kidney disease in China[J].N Engl J Med,2016,375(9):905-906.
[3]	中国慢性肾脏病患者合并高尿酸血症诊治共识专家组.中国慢性肾脏病患者合并高尿酸血症诊治专家共识[J].中华肾脏病杂志,2017,33(6):463-469.
[4]	中国医师协会肾脏内科医师分会.中国肾脏疾病高尿酸血症诊治的实践指南(2017版)[J].中华医学杂志,2017,97(25):1927-1936.
[5]	濮存莹,廖深根,郑旭辉,等.高尿酸血症预测急性心力衰竭患者长期预后的临床价值[J].临床心血管病杂志,2019,35(6):521-525.
[6]	张雄峰,李正胜,钟琴,等.慢性肾脏病合并高尿酸血症治疗的现状与挑战[J].中国全科医学,2019,22(17):2020-2024.
[7]	Levey AS,Coresh J,Balk E,et al.National Kidney Foundation practice guidelines for chronic kidney disease:evaluation,classification,and stratification[J].Ann Intern Med,2003,139(2):137-147.
[8]	Sharma S,Sarnak MJ.Epidemiology:The global burden of reduced GFR:ESRD,CVD and mortality[J].Nat Rev Nephrol,2017,13(8):447-448.
[9]	雷玉华,李元红.Lp(a)对慢性肾脏病3-5期患者冠状动脉疾病的作用研究[J].临床心血管病杂志,2019,35(10):896-898.
[10]	Zhang S,Wang Y,Cheng J,et al.Hyperuricemia and cardiovascular disease[J].Curr Pharm Des,2019,25(6):700-709.
[11]	Lin B,Shao L,Luo Q,et al.Prevalence of chronic kidney disease and its association with metabolic diseases:a cross-sectional survey in Zhejiang province,Eastern China[J].BMC Nephrol,2014,15:36-36.
[12]	Liu R,Han C,Wu D,et al.Prevalence of hyperuricemia and gout in mainland China from 2000 to 2014:A Systematic Review and Meta-Analysis[J].Biomed Res Int,2015,2015:762820.
[13]	Kumagai T,Ota T,Tamura Y,et al.Time to target uric acid to retard CKD progression[J].Clin Exp Nephrol,2017,21(2):182-192.
[14]	Bove M,Cicero AF,Veronesi M,et al.An evidence-based review on urate-lowering treatments:implications for optimal treatment of chronic hyperuricemia[J].Vasc Health Risk Manag,2017,13:23-28.
[15]	Buzas R,Tautu OF,Dorobantu M,et al.Serum uric acid and arterial hypertension-Data from Sephar III survey[J].PLoS One,2018,13(7):e0199865.
[16]	张静平,曹婧婧,王滨燕,等.华东地区成人高血压人群中血尿酸水平与臂踝脉搏波传导速度的关联性分析[J].中华疾病控制杂志,2019,23(4):441-444,458.
[17]	马为,杨颖,齐丽彤,等.北京市社区人群血尿酸水平与肱-踝动脉脉搏波传导速度的关系[J].中华心血管病杂志,2012,40(3):204-208.
[18]	Rebora P,Andreano A,Triglione N,et al.Association between uric acid and pulse wave velocity in hypertensive patients and in the general population:a systematic review and meta-analysis[J].Blood Press,2020,29(4):220-231.
[19]	郝恩刚,于仁亮,常方圆,等.血浆同型半胱氨酸水平与非ST段抬高型急性冠脉综合征患者冠状动脉病变严重程度及预后关系研究[J].临床急诊杂志,2019,20(3):189-194.
[20]	贾雪琦,薛宁,徐灵菡,等.慢性肾脏病患者血浆同型半胱氨酸水平与左心室肥厚的相关性[J].上海医学,2016,39(7):407-412.
[21]	邢艳粉,李永伟.高血压患者同型半胱氨酸与肾功能及凝血指标的相关性研究[J].中华检验医学杂志,2018,41(12):952-958.
[22]	李甲勇,彭霞,李莉.肾移植术后患者血清的同型半胱氨酸和血脂水平及与肾功能的相关性[J].中华检验医学杂志,2016,39(9):690-694.